• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与遗传性或获得性蛋白 S 缺乏相关的 TFPI 抵抗。

TFPI resistance related to inherited or acquired protein S deficiency.

机构信息

Université de Lyon, F-42023, Saint-Etienne, France.

出版信息

Thromb Res. 2012 Dec;130(6):925-8. doi: 10.1016/j.thromres.2012.07.025. Epub 2012 Oct 15.

DOI:10.1016/j.thromres.2012.07.025
PMID:23079294
Abstract

BACKGROUND

Protein S (PS) is an essential component of the protein C pathway and PS deficiency can explain a poor response to activated protein C. It has recently been shown that PS also acts as a cofactor of Tissue Factor Pathway Inhibitor (TFPI).

OBJECTIVES

In the present study, we investigated whether PS deficiency could be responsible for a poor response to TFPI.

PATIENTS/METHODS: Thirty-one patients with inherited PS deficiency, seven pregnant women and 36 controls were enrolled in the study. We measured the plasma response to added TFPI using a two-step diluted prothrombin time (dPT) assay. The response of the different plasmas to the anticoagulant activity of TFPI was expressed as TFPI Normalised Ratio (TFPI NR).

RESULTS

The median TFPI NR was statistically significantly lower in patients with inherited PS deficiency (0.5) than in controls (1.0) (p<0.0001). It was statistically significantly lower in patients with type I inherited PS deficiency (0.47) compared to patients with type III inherited PS deficiency (0.58) (p=0.018). In contrast, it did not differ between patients with and without thrombosis. Median TFPI NR values were statistically significantly lower during pregnancy (0.54) than 3 months after delivery (0.71) (p=0.016). TFPI NR values correlated well with PS activity values (R(2)=0.681) whatever the nature of the PS deficiency.

CONCLUSIONS

Our findings confirm that PS deficiency results in a poor anticoagulant response to TFPI, demonstrating again the cofactor role of PS in TFPI activity.

摘要

背景

蛋白质 S(PS)是蛋白 C 途径的重要组成部分,PS 缺乏可导致蛋白 C 激活后的反应不佳。最近的研究表明,PS 还可作为组织因子途径抑制物(TFPI)的辅助因子。

目的

本研究旨在探讨 PS 缺乏是否可导致 TFPI 反应不佳。

患者/方法:31 例遗传性 PS 缺乏症患者、7 例孕妇和 36 例对照者纳入研究。采用两步稀释凝血酶原时间(dPT)检测法测量添加 TFPI 后血浆的反应。不同血浆对 TFPI 抗凝活性的反应以 TFPI 归一化比值(TFPI NR)表示。

结果

遗传性 PS 缺乏症患者的中位 TFPI NR 显著低于对照组(0.5 比 1.0)(p<0.0001)。与 III 型遗传性 PS 缺乏症患者(0.58)相比,I 型遗传性 PS 缺乏症患者(0.47)的 TFPI NR 显著降低(p=0.018)。然而,TFPI NR 与血栓形成与否无关。与产后 3 个月(0.71)相比,妊娠期的中位 TFPI NR 值显著降低(0.54)(p=0.016)。无论 PS 缺乏的类型如何,TFPI NR 值与 PS 活性值均呈良好相关性(R2=0.681)。

结论

本研究结果证实 PS 缺乏可导致 TFPI 抗凝反应不佳,再次证明 PS 在 TFPI 活性中作为辅助因子的作用。

相似文献

1
TFPI resistance related to inherited or acquired protein S deficiency.与遗传性或获得性蛋白 S 缺乏相关的 TFPI 抵抗。
Thromb Res. 2012 Dec;130(6):925-8. doi: 10.1016/j.thromres.2012.07.025. Epub 2012 Oct 15.
2
Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels.肝硬化患者蛋白 S 降低但 TFPI 血浆水平正常时,组织因子途径抑制物(TFPI)依赖性抗凝能力降低。
Br J Haematol. 2013 Sep;162(6):819-26. doi: 10.1111/bjh.12462. Epub 2013 Jul 11.
3
TFPI-dependent activities of protein S.蛋白 S 的 TFPI 依赖性活性。
Thromb Res. 2012 May;129 Suppl 2:S23-6. doi: 10.1016/j.thromres.2012.02.024. Epub 2012 Mar 15.
4
Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.组织因子途径抑制剂的抗凝活性:静脉血栓形成风险及激素状态的影响。
Br J Haematol. 2006 Feb;132(3):333-8. doi: 10.1111/j.1365-2141.2005.05876.x.
5
Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia.蛋白 S 和组织因子途径抑制剂在有子痫前期病史的孕妇妊娠早期激活蛋白 C 抵抗中的作用。
Thromb Haemost. 2011 Nov;106(5):914-21. doi: 10.1160/TH11-04-0244. Epub 2011 Oct 6.
6
Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.组织因子途径抑制物在冠状动脉疾病中的抗凝与酰胺水解活性比较
Blood Coagul Fibrinolysis. 2000 Apr;11(3):285-91.
7
Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma.遗传性和获得性蛋白 S 缺乏与血浆中 TFPI 水平降低有关。
J Thromb Haemost. 2010 Feb;8(2):294-300. doi: 10.1111/j.1538-7836.2009.03712.x. Epub 2009 Nov 30.
8
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.不同激素避孕药对血浆游离蛋白 S 和游离 TFPI 水平的影响。
Thromb Haemost. 2013 Apr;109(4):606-13. doi: 10.1160/TH12-10-0771. Epub 2013 Feb 14.
9
High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.肾病性蛋白尿患者体内组织因子途径抑制剂水平升高。
Thromb Haemost. 1999 Sep;82(3):1020-3.
10
New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma.新型功能测定法,可选择性定量测定血浆蛋白 S 中激活蛋白 C 和组织因子途径抑制物-辅因子的活性。
J Thromb Haemost. 2017 May;15(5):950-960. doi: 10.1111/jth.13657. Epub 2017 Mar 20.

引用本文的文献

1
How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?高危妊娠患者如何改善二级血栓预防?
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296211070004. doi: 10.1177/10760296211070004.
2
Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation.肝素、香豆素、蛋白 C、抗凝血酶、纤维蛋白溶解和其他凝血相关抵抗:凝血的新概念。
J Thromb Thrombolysis. 2018 Jan;45(1):135-141. doi: 10.1007/s11239-017-1559-0.
3
Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study.
组织因子途径抑制剂用于预测高危女性胎盘介导的不良妊娠结局:血管生成预测研究。
PLoS One. 2017 Mar 22;12(3):e0173596. doi: 10.1371/journal.pone.0173596. eCollection 2017.